12.06.10
ChromaDex Corporation, Irvine, CA, has entered a global agreement with Kappa Bioscience AS, Oslo, Norway, to supply analytical reference standards, quality control methods and related analytical testing services for vitamin K2, menaquinone-7 (MK-7) in raw materials and finished goods. Vitamin K2 is shown to have significant importance for optimal utilization of calcium in the body related to bone and cardiovascular health.
“With increasing market demand for Vitamin K2 MK-7, there will be an increase in demand for reference standards, quality control methods, research tools and analytical services,” said Frank Jaksch, CEO and co-founder of ChromaDex. “Since MK-7 is a vitamin product manufactured from different sources, it is critical that testing procedures are in place to ensure the quality and consistency of any MK-7 related ingredient or product.”
“With increasing market demand for Vitamin K2 MK-7, there will be an increase in demand for reference standards, quality control methods, research tools and analytical services,” said Frank Jaksch, CEO and co-founder of ChromaDex. “Since MK-7 is a vitamin product manufactured from different sources, it is critical that testing procedures are in place to ensure the quality and consistency of any MK-7 related ingredient or product.”
